Study identifier:SD-004-0620
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Placebo-controlled comparison of the efficacy and safety of the current US version of Pulmicort (Budesonide) Turbuhaler and the new version of Pulmicort Turbuhaler in asthmatic adults currently treated with inhaled steroids.
asthma
Phase 3
No
budesonide, Placebo
All
525
Interventional
18 Years +
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
A comparison of the safety, efficacy and budesonide pharmacokinetics of the currently approved Pulmicort Turbuhaler with a new version of the inhaler, in adult patients who have asthma and are currently being treated with inhaled steroids. In addition the study evaluated the functionality of the new inhaler at the end of its intended life.
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 Pulmicort | - |
Placebo Comparator: 2 Placebo | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.